2008
Psoriasis: an opportunity to identify cardiovascular risk
Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis: an opportunity to identify cardiovascular risk. British Journal Of Dermatology 2008, 160: 1-7. PMID: 19016698, DOI: 10.1111/j.1365-2133.2008.08874.x.Peer-Reviewed Original ResearchConceptsCardiovascular risk factorsCardiovascular riskRisk factorsTreatable cardiovascular risk factorsPatients' cardiovascular riskMyocardial infarctionSevere diseaseHealth professionalsPsoriasisPatientsRiskLow qualityAssociationArthritisInfarctionAtherosclerosisInflammationMortalityFactorsPrevalenceDermatologistsDiseaseComplaints
2006
Full-Body Skin Examinations and the Female Veteran: Prevalence and Perspective
Federman DG, Kravetz JD, Haskell SG, Ma F, Kirsner RS. Full-Body Skin Examinations and the Female Veteran: Prevalence and Perspective. JAMA Dermatology 2006, 142: 312-316. PMID: 16549706, DOI: 10.1001/archderm.142.3.312.Peer-Reviewed Original ResearchConceptsFull-body skin examinationPrimary care providersCare providersFemale veteransSkin cancerSkin examinationRisk factorsPrimary health care clinicsVeterans Affairs Medical CenterPatient risk factorsHealth care clinicsPercent of subjectsCare clinicsClinic appointmentsCutaneous malignanciesLower incidencePatient reportsMedical CenterCancer altersScreening testPatientsCancerConvenience sampleVeteransPersonal history
2005
Skin Cancer and Non-Hodgkin's Lymphoma
HU S, FEDERMAN D, MA F, KIRSNER R. Skin Cancer and Non-Hodgkin's Lymphoma. Dermatologic Surgery 2005, 31: 76-82. DOI: 10.1097/00042728-200501000-00014.Peer-Reviewed Original ResearchSkin cancerHodgkin's lymphomaCommon environmental risk factorsLarge population-based studyHistory of NHLDevelopment of NHLPopulation-based studyIncidence of NHLNon-Hodgkin lymphomaFull-body examinationSkin cancer developmentEnvironmental risk factorsRisk factorsIncidence rateEpidemiologic studiesPubMed searchClinical practiceNHLLymphomaUltraviolet light exposureCancerCancer developmentPatientsCurrent literatureRisk
2004
Full-Body Skin Examinations: The Patient's Perspective
Federman DG, Kravetz JD, Tobin DG, Ma F, Kirsner RS. Full-Body Skin Examinations: The Patient's Perspective. JAMA Dermatology 2004, 140: 530-534. PMID: 15148096, DOI: 10.1001/archderm.140.5.530.Peer-Reviewed Original ResearchConceptsPrimary care practitionersSkin cancerRisk factorsWest Haven Veterans Affairs Medical CenterVeterans Affairs Medical CenterPatient risk factorsPercent of participantsPatient questionnaireClinic appointmentsCutaneous malignanciesDermatology clinicExamination ratePrimary careLower incidencePatient reportsMedical CenterPatient's perspectiveCare practitionersCancer altersPatientsScreening testCancerConvenience samplePersonal historyLower rates
2001
Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. PMID: 11702815, DOI: 10.1097/00007611-200110000-00016.Peer-Reviewed Original ResearchConceptsStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesCliniciansFatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. DOI: 10.1097/00007611-200194100-00017.Peer-Reviewed Original ResearchStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesClinicians
1998
Epidemiology of peripheral vascular disease: a predictor of systemic vascular disease.
Federman D, Trent J, Froelich C, Demirovic J, Kirsner R. Epidemiology of peripheral vascular disease: a predictor of systemic vascular disease. Wound Management & Prevention 1998, 44: 58-62, 64, 66 passim. PMID: 9697547.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseaseSystemic vascular diseaseSymptomatic peripheral vascular diseaseBody mass indexVascular diseaseRisk factorsPrevalence of PVDLower body mass indexCoronary artery diseaseCoronary heart diseasePhysical examination findingsImportant risk factorArtery diseaseHDL cholesterolExamination findingsLow ABIMass indexCerebrovascular diseaseCigarette smokingHeart diseasePhysical activityAdult populationOrgan systemsDiseasePatients